Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability.

Lung cancer (Amsterdam, Netherlands)·2026

Same author

Extra-appendiceal low-grade mucinous neoplasm-like lesions: clinicopathologic and molecular characteristics.

Histopathology·2026

Same author

Digital Ki-67 quantification in neuroendocrine tumours: comparing performance of camera-captured images and open-source platforms across imaging modalities.

Journal of clinical pathology·2026

Same author

Chondroblastoma with prominent secondary aneurysmal bone cyst-like changes: The role of H3.3 K36 M.

Human pathology·2026

Same author

Primary gallbladder carcinomas showing pancreatic acinar features in the absence of a pancreatic primary.

Histopathology·2026

Same author

Quo Vadis colorectal intramucosal adenocarcinoma?

Journal of clinical pathology·2026

Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026

Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026

Same journal

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026

Same journal

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026

Same journal

Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

Journal of clinical pathology·2026

Same journal

Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

Journal of clinical pathology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 7, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

MDM2 for the practicing pathologist: a primer.

Aswathy Ashok Menon¹, Vikram Deshpande², David Suster³

¹Department of Pathology, Neuberg Anand Reference Laboratory, Bengaluru, Karnataka, India.

Journal of Clinical Pathology

|March 10, 2023

Summary

This summary is machine-generated.

The mouse double minute 2 (MDM2) gene regulates p53, a tumor suppressor. MDM2 alterations contribute to cancer, and its amplification aids in diagnosing specific tumors.

Keywords:

DIAGNOSIS GENE AMPLIFICATION Sarcoma

More Related Videos

Human Lung Dendritic Cells: Spatial Distribution and Phenotypic Identification in Endobronchial Biopsies Using Immunohistochemistry and Flow Cytometry

Human Lung Dendritic Cells: Spatial Distribution and Phenotypic Identification in Endobronchial Biopsies Using Immunohistochemistry and Flow Cytometry

Published on: January 20, 2017

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Published on: June 29, 2020

Related Experiment Videos

Last Updated: Aug 7, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Human Lung Dendritic Cells: Spatial Distribution and Phenotypic Identification in Endobronchial Biopsies Using Immunohistochemistry and Flow Cytometry

Human Lung Dendritic Cells: Spatial Distribution and Phenotypic Identification in Endobronchial Biopsies Using Immunohistochemistry and Flow Cytometry

Published on: January 20, 2017

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Published on: June 29, 2020

Area of Science:

Molecular Biology
Genetics
Oncology

Background:

The mouse double minute 2 (MDM2) gene is the primary negative regulator of the p53 tumor suppressor protein.
MDM2 encodes an E3 ubiquitin-protein ligase, mediating p53 ubiquitination and degradation, thereby promoting tumor formation.
MDM2 possesses p53-independent functions, and its alterations are implicated in various human tumors and non-neoplastic diseases.

Purpose of the Study:

To provide a concise overview of the MDM2 gene.
To discuss the practical diagnostic applications of MDM2 alterations in human tumor biology.

Main Methods:

Review of existing literature on MDM2 gene function, alterations, and diagnostic utility.
Analysis of the role of MDM2 amplification in specific tumor types.

Main Results:

MDM2 amplification is a clinically relevant diagnostic marker for lipomatous neoplasms, low-grade osteosarcomas, and intimal sarcoma.
MDM2 alterations are associated with adverse prognosis in various cancers.
MDM2-targeted therapies are under investigation in clinical trials.

Conclusions:

MDM2 plays a critical role in tumor biology through both p53-dependent and independent pathways.
Detection of MDM2 amplification is valuable for diagnosing specific tumors and predicting prognosis.
Targeting MDM2 represents a promising therapeutic strategy in oncology.